Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes.
Dobosh B, Zandi K, Giraldo DM, Goh SL, Musall K, Aldeco M, LeCher J, Giacalone VD, Yang J, Eddins DJ, Bhasin M, Ghosn E, Sukhatme V, Schinazi RF, Tirouvanziam R.
Dobosh B, et al. Among authors: aldeco m.
Cell Rep. 2022 Jun 14;39(11):110945. doi: 10.1016/j.celrep.2022.110945. Epub 2022 May 25.
Cell Rep. 2022.
PMID: 35688145
Free PMC article.